Push release MHRA approves GLP –1 receptor agonist semaglutide to lessen threat of serious heart issues in obese or overweight adults Semaglutide is the primary weightloss drug authorised in britain being a preventative remedy for all those with proven heart problemsBe a part of our specialist staff – created up of GPs and nutritionists – To … Read More